Linked Life Data

7757975

Source:http://linkedlifedata.com/resource/pubmed/id/7757975

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1995-6-29
pubmed:abstractText
Cancer is a multistep process that involves the activation of oncogenes and the inactivation of antioncogenes. Recently, a new putative tumor suppressor, the neurofibromatosis type 2 (NF2) gene, was mapped to chromosome 22, cloned, and found to encode for a new protein, merlin/schwannomin, a member of the band 4.1 family of proteins. Members of this family have not been implicated previously in tumorigenesis. They possess significant homology in their NH2-terminal domain, which is thought to be important in the binding of the plasma membrane to the underlying actin cytoskeleton. To determine whether schwannomin may affect cell growth, we transfected NIH 3T3 cells with the wild type and an NF2 cDNA lacking 111 amino acids at the NH2 terminus. We observed slowing of growth and changes in cellular morphology only in cells expressing the wild-type NF2 cDNA. This finding suggests that schwannomin can suppress growth directly and confirms its role in tumor suppression. This system will provide a useful assay to identify important functional domains of the protein.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
55
pubmed:geneSymbol
NF2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2270-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
pubmed:affiliation
Centre for Research in Neurosciences, McGill University, Montreal, Quebec, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't